Supernus Pharmaceuticals holds special stockholder meeting
SUPN•Supernus Pharmaceuticals shareholders adopted the merger agreement with Indivior at a special meeting on October 15, 2026.
SUPN•SUPN•SUPN•Supernus Pharmaceuticals shareholders adopted the merger agreement with Indivior at a special meeting on October 15, 2026.
Supernus Pharmaceuticals shareholders adopted the merger agreement with Indivior at a special meeting on October 15, 2026. Under the agreement, Artemis Merger Sub would merge into Supernus, leaving Supernus as a wholly owned subsidiary of Indivior.
